Anti-microRNAs are possible new therapeutic target for type 2 diabetes
Researchers have shown that targeted silencing of microRNA-132, which is over-expressed in type 2 diabetes, can result in improved insulin secretion and reduced blood glucose in mice and increased insulin secretion in isolated ...
Feb 7, 2019
0
4